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Summary
The Escherichia coli K-12 strain KPM22, defective
in synthesis of 3-deoxy-D-manno-oct-2-ulosonic
acid (Kdo), is viable with an outer membrane (OM)
composed predominantly of lipid IVA, a precursor of
lipopolysaccharide (LPS) biosynthesis that lacks any
glycosylation. To sustain viability, the presence of a
second-site suppressor was proposed for transport
of lipid IVA from the inner membrane (IM), thus reliev-
ing toxic side-effects of lipid IVA accumulation and
providing sufficient amounts of LPS precursors to
support OM biogenesis. We now report the identifica-
tion of an arginine to cysteine substitution at position
134 of the conserved IM protein YhjD in KPM22 that
acts as a compensatory suppressor mutation of the
lethal DKdo phenotype. Further, the yhjD400 suppres-
sor allele renders the LPS transporter MsbA dispens-
able for lipid IVA transmembrane trafficking. The
independent derivation of a series of non-conditional
KPM22-like mutants from the Kdo-dependent parent
strain TCM15 revealed a second class of suppressor
mutations localized to MsbA. Proline to serine substi-
tutions at either residue 18 or 50 of MsbA relieved the
Kdo growth dependence observed in the isogenic
wild-type strain. The possible impact of these sup-
pressor mutations on structure and function are
discussed by means of a computationally derived
threading model of MsbA.
Introduction
The cell envelope of Gram-negative bacteria contains, in
addition to the inner membrane (IM) and the peptidogly-
can layer, a bilayered and asymmetrically organized outer
membrane (OM). The OM inner leaflet consists of various
glycerophospholipids, while the outer leaflet predomi-
nantly contains lipopolysaccharide (LPS). LPS is a
complex amphiphilic molecule composed of a hydrophilic
heteropolysaccharide and the OM-embedded lipid A. The
polysaccharide component of many wild-type bacteria
can be subdivided into the O-specific polysaccharide
chain and an outer and inner core oligosaccharide.
Enterobacterial lipid A represents together with the inner
core region a rather conserved LPS domain. The struc-
tural heterogeneity increases distal to lipid A and the inner
core, with the terminal O-specific chain being the most
variable part of the LPS molecule (Mamat et al., 1999;
Raetz and Whitfield, 2002). The eight-carbon sugar
3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) is the only
conserved structural element found in all inner core
regions investigated so far, linking lipid A to the carbohy-
drate domain of LPS (Holst, 2007).
Biosynthesis of LPS is a transmembrane process initi-
ated at the cytoplasmic face of the IM. In Wzy-dependent
Escherichia coli strains, the lipid A-core part and the
O-specific chain repeating units are synthesized sepa-
rately at the cytoplasmic side of the IM, followed by trans-
fer of the units through the IM by specific translocators. At
the periplasmic face of the membrane, the O-antigen
repeats are ligated to the LPS-core acceptor molecule
before the eventual translocation to its final location in the
outer leaflet of the OM via ill-defined processes (Raetz
and Whitfield, 2002). The transbilayer movement of lipid
A-core molecules from the cytoplasmic to the periplasmic
face of the IM is dependent on MsbA (Zhou et al., 1998;
Doerrler et al., 2004), an essential protein of the ATP-
binding cassette (ABC) transporter superfamily (Karow
and Georgopoulos, 1993; Polissi and Georgopoulos,
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1996), which includes mammalian membrane transport-
ers such as the human multidrug resistance P-
glycoprotein MDR1 (Borges-Walmsley and Walmsley,
2001), and the bacterial multidrug transporters LmrA of
Lactococcus lactis (van Veen et al., 1996) and Sav1866 of
Staphylococcus aureus (Dawson and Locher, 2006).
MsbA was originally identified as a multicopy suppressor
of the temperature-sensitive phenotype of htrB (lpxL)
mutants (Karow and Georgopoulos, 1993; Polissi and
Georgopoulos, 1996) that accumulated tetraacylated lipid
A species and phospholipids in the IM at non-permissive
temperatures (Zhou et al., 1998). Subsequent studies
characterized MsbA as highly selective for hexaacylated
LPS/lipid A substrates (Doerrler and Raetz, 2002), con-
sistent with earlier observations that E. coli and Salmo-
nella enterica sv. Typhimurium do not efficiently transport
underacylated lipid A species to the OM (Osborn et al.,
1980; Nishijima and Raetz, 1981).
It has long been recognized that non-conditional Kdo
pathway mutants of E. coli are not viable and conse-
quently the minimal LPS structure required for growth of
E. coli cells is two Kdo residues attached to lipid A
(Gronow and Brade, 2001; Raetz and Whitfield, 2002).
However, we previously reported the isolation of the non-
conditional E. coli K-12 Kdo pathway null mutant KPM22
from the auxotrophic parent strain TCM15. KPM22, defec-
tive in the D-arabinose 5-phosphate isomerases (API)
KdsD and GutQ, lacks Kdo and is viable despite predomi-
nantly elaborating the lipid A precursor lipid IVA, thus rede-
fining the minimal LPS structure capable of supporting
OM biogenesis in E. coli (Meredith et al., 2006). Several
lines of evidence indicated the development of a compen-
satory suppressor mutation(s) that enables KPM22 to tol-
erate null mutations in Kdo pathway genes. It was shown
that increased levels of MsbA on a multicopy plasmid can
directly rescue the auxotrophic parent strain from the oth-
erwise lethal DKdo phenotype without the need to develop
the presumed suppressor mutation, thereby indirectly
implicating a role for the unmapped suppressor in trans-
port of lipid IVA to the OM.
In this report, a P1vir co-transductional mapping
approach has been used to identify the suppressors of
Kdo dependence in KPM22 and in a series of indepen-
dently derived KPM22-like mutants. It is shown that at
least two classes of mutations arise to suppress Kdo
essentiality. Single amino acid substitutions in either
MsbA or the unknown integral IM protein YhjD relegate
Kdo pathway genes dispensable in an otherwise isogenic
wild-type E. coli K-12 background when cultured under
standard growth conditions. A putative function for the
YhjD suppressor protein in lipid transport is proposed that
suggests an MsbA-independent suppressor-facilitated
lipid A translocation pathway in KPM22. In addition,
a computationally derived three-dimensional model of
MsbA is presented to gain insight into the mechanism of
LPS/lipid A flip-flop by MsbA.
Results
Mapping of the suppressor mutation of KPM22
Our previous studies on the DKdo phenotype indicated
that E. coli TCM15, the D-arabinose 5-phosphate (A5P)
auxotrophic parent strain of KPM22, readily regains its
colony-forming ability on solid A5P-free medium in the
presence of a presumed suppressor mutation or when
multiple copies of MsbA are provided in trans (Meredith
et al., 2006). Accordingly, this selection technique was
utilized to map the unknown suppressor mutation in
KPM22. A library of kanamycin-marked Tn903 insertion
mutants was generated in KPM22, and a P1vir donor
lysate was obtained from the pooled transposon library.
Selection on kanamycin plates lacking A5P identified
co-transductants in which the auxotrophic TCM15 strain
had become non-conditional for A5P. Determination of
co-transduction frequencies by two-marker P1vir trans-
ductional mapping from a total of 25 co-transductants
revealed a co-transducible linkage of 80% between the
Tn903 insertion and the suppressor mutation in isolate
KPM96. The Tn903 insertion site in KPM96 was mapped
to the genomic gadA-yhjJ region, which was obtained
as two overlapping inserts of 7.1 kb and 15.3 kb in
pMMW84 and pMMW86 by subcloning of genomic DNA
fragments (Fig. 1). Analysis of the DNA sequence of the
15.8 kb region identified Tn903 inserted in the cytoplas-
mic trehalase gene treF. More importantly, a C:G to T:A
transition at base number 400 of the yhjD gene was
found in close proximity to the insertion site of the kana-
mycin resistance cassette. YhjD is a conserved inner
membrane protein of unknown function. The point muta-
tion of the yhjD400 allele causes a substitution of an Arg
to a Cys residue at position 134. KPM22 was sequenced
directly and confirmed the presence of the mutant
yhjD400 allele, while the mutation was not present in
TCM15, which had the wild-type yhjD sequence (Fig. 1).
Taken together, this suggests that the yhjD400 allele
can function as a compensatory suppressor of Kdo
depletion.
Deletion of waaA in BW30270 carrying the
yhjD400 allele
Attachment of two Kdo residues to lipid IVA by the Kdo
transferase WaaA is thought to be essential for viability
of E. coli, and attempts to isolate non-conditional
mutants of Kdo transferase have not been successful
(Belunis et al., 1995). We therefore examined the capa-
bility of the yhjD400 allele to suppress a waaA null
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mutation in the E. coli K-12 wild-type strain BW30270.
KPM96 was used as the donor for co-transfer of
yhjD400 and treF::Tn903 to BW30270 via P1vir trans-
duction to yield strain MAW01, which subsequently
served as the host for deletion of the waaA gene. The
resulting strain KPM121, carrying the yhjD400 allele
(Fig. 1), was indeed viable and capable of maintaining
the normally lethal DwaaA mutation. KPM121 showed a
growth rate strikingly similar to that of KPM22 (data not
shown). Investigation of the LPS precursor of KPM121
by mass spectrometry revealed two prominent LPS
related peaks with molecular masses of 1404.85 u and
1527.87 u, consistent with the structures of the tetraacyl-
1,4′-bisphosphate LPS precursor lipid IVA (calculated
mass 1404.854 u) and lipid IVA modified with a pho-
sphoethanolamine (P-EtN) group (calculated mass
1527.863 u), respectively (Fig. 2A). The late acyltrans-
ferases LpxL and LpxM exhibit an extremely high speci-
ficity for Kdo2-lipid IVA substrate both in vitro (Brozek and
Raetz, 1990) and in vivo (Meredith et al., 2006), explain-
ing the lack of the lauroyl and myristoyl chains. Thus,
these results strongly support the conclusion that the
yhjD400 allele is a suppressor of the lethal DKdo phe-
notype in E. coli. The survival of the BW30270-derived
strain KPM121, which elaborates non-glycosylated lipid
A intermediates as a result of a DwaaA knockout in the
presence of the yhjD400 allele, suggests that the sup-
pressor is not specifically associated with the DAPI
background of KPM22 and that no other additional
mutations are co-required for suppression.
The yhjD400 allele is essential to rescue yhjD-deficient
TCM15 and KPM22 mutants under conditions of
A5P depletion
In order to obtain additional evidence for the decisive
role of the yhjD400 allele in sustaining viability of E. coli
strains defective in the Kdo pathway, we proceeded to
investigate the growth rates of TCM15 and KPM22
derivatives carrying chromosomal yhjD deletions that
have been complemented with both the wild-type and
the mutated allele of yhjD on a plasmid (Table 1). Dis-
ruption of the yhjD and yhjD400 genes in TCM15 and
KPM22 yielded the strains MAW03 and MAW06, respec-
tively, which were viable provided that A5P was included
in the medium. Under these conditions, MAW03 and
MAW06 displayed almost identical growth rates as their
parental strains (TCM15 and KPM22), indicating that
yhjD in fact is dispensable. Thus, the recent classifica-
tion of yhjD as a non-essential gene in wild-type E. coli
is confirmed (Baba et al., 2006). However, MAW06, like
MAW03, ceased to grow exponentially after two to three
generations in LB medium without A5P, suggesting a
direct correlation between the recovery of the A5P aux-
otrophic phenotype and the loss of the yhjD400 allele in
MAW06. To assess the ability of yhjD400 to subvert
the A5P auxotrophic phenotype of MAW03 and MAW06,
the strains MAW05 and MAW08 were constructed, each
containing the plasmid pT7LOHyhjD400. The strains
MAW03 and MAW06 were additionally transformed with
pT7LOHyhjD to generate the strains MAW04 and
Fig. 1. Genetic organization of the gadA-yhjJ
region of E. coli K-12. The KPM96-derived
EcoRI and PstI inserts of pMMW84 and
pMMW96, respectively, carry the Tn903
transposon inserted in treF. The C:G to T:A
transition at base number 400 of the yhjD
gene (underlined) causes an Arg to Cys
substitution at position 134 (underlined). The
BsiWI recognition sequence in the wild-type
yhjD gene of BW30270 and TCM15, used to
screen KPM22-like mutants for the presence
of the yhjD400 allele, is shown in italics.
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MAW07, respectively, and used as controls in subse-
quent complementation experiments. As expected, the
control strains MAW04 and MAW07 grew only in the
presence of exogenous A5P, whereas the strains rapidly
ceased to grow when A5P was omitted. In contrast, the
yhjD400 allele was capable of converting MAW05 and
MAW08 into non-conditional DAPI mutants. Although the
strains had a doubling time in LB medium approximately
twice as long as in medium supplemented with A5P, the
generation time of both the MAW05 and the MAW08
strain was similar to that of KPM22 in LB medium alone.
The data provides further evidence that the yhjD400
allele is essential to sustain viability of A5P auxotrophic
strains under non-permissive conditions, whereas mul-
tiple copies of the wild-type yhjD allele does not exhibit
any suppressor activity. Collectively, we conclude that
the yhjD400 mutation imparts suppression not through
a loss of protein function, but rather by modifying its
activity.
Identification of msbA52 and msbA148 as suppressors
of Kdo depletion in KPM22-like mutants
To address the possibility that mutations other than the
yhjD400 allele may suppress the lethal phenotype asso-
ciated with Kdo depletion, a series of independent, non-
clonal DKdo suppressor derivatives of TCM15 that we call
KPM22-like mutants were isolated. The yhjD loci were
Fig. 2. Charge deconvoluted ESI FT-ICR
mass spectra in negative ion mode of LPS
molecules isolated from KPM121 (A),
KPM22 L1 (inset structure of lipid IVA) (B) and
KPM231 (C). Mass numbers given refer to the
monoisotopic masses of neutral lipid A
precursor molecules. Lipid IVA (1404.86 u)
modified with a phosphoethanolamine (P-EtN)
group (1527.87 u) and with a palmitate chain
(lipid IVB) (1643.09 u), as well as peaks
presumably representing lipid IVA molecules
with variations in acyl chain length (1390.84 u
and 1376.82 u), are labelled. The peak
corresponding to LAtri (1178.66 u) is likely an
artefact produced during lipid IVA isolation
and/or ionization as it is not consistent with a
known pathway intermediate.
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amplified from the KPM22-like mutants and then digested
with BsiWI to screen for the yhjD400 allele. The single
BsiWI recognition sequence within yhjD is destroyed upon
conversion to yhjD400 (see Fig. 1). Besides re-identifying
the yhjD400 mutation in a number of new KPM22-like
mutants, we found several strains containing the wild-type
allele of yhjD. This suggested a second yhjD-independent
suppression mechanism was operative, and so the rep-
resentative strain KPM22 L1 was chosen for further
analysis. Electrospray ionization Fourier transform ion
cyclotron (ESI FT-ICR) mass spectrometry of LPS from
KPM22 L1 once again revealed the nearly exclusive peak
of lipid IVA [1404.86 u (Fig. 2B)], supporting the conclu-
sion for the existence of another suppressor that enables
KPM22 L1 to survive despite lacking Kdo. To map the
suppressor mutation in KPM22 L1, we employed the
same P1vir co-transductional mapping approach essen-
tially as described above for the identification of the
yhjD400 mutation. Sequence analysis was performed
on two overlapping PCR products, covering the
9.6 kb genomic aroA-msbA region of the co-transductant
KPM129 downstream of the subclone pMMW91 insert
(Fig. 3). The Tn903 integration site was not determined. A
C:G to T:A transition at base number 148 was found within
the coding region of the ABC transporter gene msbA,
resulting in a Pro to Ser substitution at position 50. The
sequence of the msbA148 allele in KPM129 perfectly
matched that of KPM22 L1, whereas TCM15 was shown
to contain the wild-type allele of BW30270 (Fig. 3). Fortu-
itously, this mutant allele could also be rapidly screened
for by DNA restriction analysis in an analogous fashion
using the MwoI site at position 145. Amplification of the
msbA gene from KPM22-like mutants, screening for
restriction modification, and DNA sequence analysis iden-
tified yet another mutation residing within msbA in the
non-conditional DAPI mutant KPM22 L11 (Fig. 3). The
msbA52 suppressor allele is also a C:G to T:A transition
that results in another Pro to Ser substitution but closer to
the N-terminus at position 18. To verify that msbA148 acts
as a suppressor of the DKdo phenotype, we generated the
DwaaA knockout strain KPM231 on the basis of MAW02,
which is a derivative of BW30270 obtained by transfer of
the msbA148 allele from KPM129 via P1vir transduction.
The non-conditional strain KPM231, defective in attach-
ment of Kdo to the lipid A backbone, was viable in the
presence of msbA148. As a result, only tetraacylated lipid
A precursors were detected. In addition to lipid IVA, lipid
Table 1. Suppression of DA5P auxotrophy by the yhjD400 allele in













a. LB medium containing 15 mM A5P and 10 mM G6P.
b. Not applicable. Strains ceased to grow after two to three
generations.
Fig. 3. Genetic organization of the
ycaO-lpxK′ locus of E. coli K-12. The PstI
insert on pMMW91 and the DNA sequence
spanning the region between aroA and msbA
were obtained from KPM129. The C:G to T:A
transitions at base numbers 148 and 52,
leading in both cases to a Pro to Ser
substitution at positions 50 and 18,
respectively, are underlined. The MwoI
recognition sequence at position 145 of the
msbA wild-type gene in BW30270 and
TCM15 used to screen for the msbA148 allele
in KPM22-like mutants is shown in italics.
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IVA modified with either P-EtN or substituted with a palmi-
tate chain [lipid IVB, calculated mass 1643.084 u (Bishop
et al., 2000)] could be assigned (Fig. 2C). Taken together,
the results allow us to draw the conclusion that both the
P18S and the P50S substitution in MsbA are suppressors
of the lethal DKdo phenotype and hence enable E. coli
strains to survive without the Kdo pathway.
Quantification of msbA gene expression
The capability of multiple MsbA copies to directly rescue
the auxotrophic parent strain TCM15 from the lethal DKdo
phenotype (Meredith et al., 2006) raised the question of
whether the yhjD400 suppressor allele may lead to
elevated expression levels of the msbA mRNA in KPM22
and related strains. Therefore, competitive reverse tran-
scription polymerase chain reaction (RT-PCR) experi-
ments were performed to determine the abundance of the
msbA transcript relative to the abundance of an in vitro
synthesized competing msbA RNA standard (Fig. 4). The
standard RNA, modified by introduction of a deletion of 23
nucleotides into the target region of the msbA message,
was specifically designed to apply identical experimental
conditions for both the target and the competitor RNA in
RT-PCRs with identical primers. This establishes nearly
indistinguishable amplification kinetics for both RNAs in
the same reaction. The initial amount of the msbA target
in TCM15 and KPM22 was deduced from the ratios of
the amounts of competitive amplification products, using
6.3 ¥ 107, 3.1 ¥ 107, 1.6 ¥ 107, 7.8 ¥ 106 and 3.9 ¥ 106
copies of msbA competitor RNA and 1 mg of total RNA per
cDNA reaction mixture, respectively. Constant amounts of
the target cDNA together with decreasing amounts of the
competitor cDNA resulted in an increase of the intensity of
the upper target-derived bands of 188 bp and a decrease
of the intensity of the signals obtained from the competitor
cDNA (lower bands of 165 bp). Determination of the com-
petition equivalence points revealed nearly identical initial
amounts of the msbA target of approximately 4 ¥ 107
copies in both TCM15 and KPM22. The levels of msbA
in the auxotrophic parent strain and in the suppressor
strain are not significantly different. Furthermore, we did
not detect any meaningful variations in the amount of
the msbA target among the TCM15 derivatives MAW03,
MAW04 and MAW05, as well as in the KPM22-derived
strains MAW06, MAW07 and MAW08. Thus, regardless
of whether the yhjD gene is deleted or overexpressed
on a multicopy plasmid as either the wild-type yhjD or the
yhjD400 allele, the mRNA level of msbA remains
constant.
Deletion of msbA in KPM22
In view of underacylated LPS precursors presumably
being very poorly translocated across the IM by MsbA
(Osborn et al., 1980; Nishijima and Raetz, 1981; Zhou
et al., 1998; Doerrler and Raetz, 2002), it was not unrea-
sonable to assume that contribution of MsbA to lipid IVA
transport is negligible and therefore dispensable in E. coli
DKdo strains containing the yhjD400 mutation. To test
for a non-essential role of MsbA in KPM22, we deleted
the entire msbA coding sequence of 1749 nucleotides in
MAW09, leaving the lipid A 4′-kinase-encoding lpxK gene
of the msbA-lpxK transcriptional unit unaffected. The sub-
sequent transfer of the msbA knockout from MAW09 to
KPM22 yielded the strain KPM272, which was viable
despite lacking the msbA gene. Several attempts to addi-
tionally delete the lpxK gene in KPM22 were unsuccessful
(data not shown). This suggested that phosphorylation of
the 4′-position of the tetraacyldisaccharide 1-phosphate
Fig. 4. Quantification of msbA gene
expression by competitive RT-PCR. Equal
amounts of total RNA (1 mg) from each strain
were spiked with the indicated copies of
msbA competitor RNA. For the control
experiments, 1 mg of total RNA of the strains
was mixed each with 7.9 ¥ 107 copies of
msbA competitor RNA and subjected to
RT-PCR reactions lacking reverse
transcriptase. T, PCR product of target cDNA
(188 bp); C, PCR product of competitor cDNA
(165 bp); M, 50 bp DNA ladder marker.
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precursor of lipid A is required for viability of KPM22 as in
wild-type E. coli cells (Garrett et al., 1998). To address the
subcellular location of lipid IVA molecules and determine
whether they are transported to the OM of KPM272, the
LPS precursors were isolated from its IM and OM. ESI
FT-ICR analysis of the samples identified in decreasing
abundance lipid IVA substituted with one P-EtN group
(1527.87 u), lipid IVA (1404.86 u), and lipid IVA modified
with two P-EtN moieties (calculated mass 1650.871 u) as
constituents of both the IM and OM of KPM272 (Fig. 5).
The data collectively indicate MsbA is indeed not respon-
sible for trafficking LPS-related precursors to the OM in
strains that harbour the yhjD400 allele.
Discussion
Original studies on the Kdo8P synthase KdsA of
S. enterica sv. Typhimurium (Rick and Osborn, 1977; Rick
and Young, 1982; Raetz et al., 1985) and application of
agents specifically targeting the CMP-Kdo synthetase
KdsB of S. enterica sv. Typhimurium and E. coli (Goldman
et al., 1987; 1988) demonstrated the accumulation of
large amounts of underacylated lipid A precursors, the
arrest of cell growth and ultimately cell death as a result of
the interruption in Kdo biosynthesis. Substantial quantities
of LPS precursors accumulated in the IM, although traces
of stably integrated precursors could be detected in the
OM. It was suggested that the conditionally lethal effects
stem from a markedly diminished lipid translocation rate to
the OM, rather than an incapability of the temperature-
sensitive KdsA mutant of S. enterica sv. Typhimurium per
se to integrate lipid A precursors into the OM (Osborn
et al., 1980). However, in consideration of the fact that
the minimal LPS structure required to sustain viability of
E. coli cells had been recognized as two Kdo residues
attached to lipid A, it remained uncertain whether at least
a Kdo2-lipid A LPS substructure is actually required for
growth/OM maintenance, or whether the accumulation of
LPS precursors causes toxicity. We previously have
shown that the Kdo molecule itself is a dispensable struc-
tural component of the OM LPS layer of E. coli (Meredith
et al., 2006). The non-conditional DAPI strain KPM22 is
defective in Kdo biosynthesis and yet remains viable
despite lacking the entire LPS-core structure. It was there-
fore suggested that the suppressor mutation enables the
strain to tolerate Kdo depletion by increasing the rate
of lipid IVA transport, resulting in an adequate supply for
OM biogenesis and/or removal of lipid IVA from the IM
to attenuate toxic side-effects caused by lipid IVA
accumulation.
Fig. 5. Charge deconvoluted ESI FT-ICR
mass spectra in negative ion mode of LPS
molecules isolated from the IM (A) and OM
(B) of KPM272. Mass numbers given refer to
the monoisotopic masses of neutral lipid A
precursor molecules. Lipid IVA (1404.86 u)
substituted with one phosphoethanolamine
(P-EtN) group (1527.87 u) and with two P-EtN
moieties (1650.87 u) are labelled.
Suppressors of Kdo dependence in Escherichia coli 639
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Molecular Microbiology, 67, 633–648
Here we report that an Arg to Cys substitution at posi-
tion 134 of YhjD suppresses the lethal DKdo phenotype of
KPM22. Four lines of evidence support the conclusion
that YhjDR134C is required for viability of KPM22. First, the
presence of the yhjD wild-type allele in the auxotrophic
parent strain TCM15 argues strongly for the development
of the suppressor mutation in KPM22 during the extended
lag of more than 24 h between the shift to non-permissive
conditions and subversion of the A5P auxotrophic
phenotype. Second, the yhjD400 allele was clearly essen-
tial as well as sufficient to transform DyhjD derivatives
of both KPM22 and TCM15 without any lag into non-
conditional DAPI mutants. Third, the independent rederi-
vation of non-conditional TCM15 derivatives yielded
phenotypically equivalent KPM22-like mutants that
carried the same mutation as in KPM22. Finally, integra-
tion of the yhjD400 allele into the genome of the E. coli
K-12 wild-type strain BW30270 directly converted the nor-
mally essential waaA Kdo transferase gene into a non-
essential gene in the mutant KPM121.
Although our results implicate YhjDR134C in participation
of lipid IVA removal from the IM of Kdo-depleted E. coli
K-12 strains, elucidation of the mode of suppression by
YhjDR134C must await further investigations. An attractive
hypothesis was that the expression of YhjDR134C increases
the msbA mRNA copy number to compensate for the low
affinity of MsbA for lipid IVA and restores transport to viable
rates by simple mass action. However, we could not find
any indication of an impact of YhjDR134C on the abundance
of the msbA transcript, either in KPM22 or in DyhjD deriva-
tives of KPM22 and TCM15. At present, we cannot rule out
the possibility that the expression of MsbA is regulated
post-transcriptionally, for example, via the amount of
tRNA2Thr and/or the usage of the rare codon ACG that is
frequently found in the msbA gene (Mohri et al., 2003), and
that this is actually the underlying mechanism of suppres-
sion. Based on sequence similarities between yhjD and
yihY (b3886), thought to code for the RNase BN of E. coli
(Callahan and Deutscher, 1996), YhjD has been assigned
to a subgroup of the RNase BN-like family of rather unusual
hydrophobic RNases with five to six predicted transmem-
brane spans (Zuo and Deutscher, 2001). However, the
apparent incorrect assignment of yihY as the gene encod-
ing RNase BN (Ezraty et al., 2005) challenges the classi-
fication of YhjD as an RNase BN-like protein. Taking into
account that YhjD is a putative conserved IM protein (Daley
et al., 2005) and appears to be orthologously related to
members of the major facilitator superfamily of proteins
for transport of small molecules [Kyoto Encyclopedia of
Genes and Genomes (http://www.genome.ad.jp/kegg/
kegg2.html)] (Pao et al., 1998), we currently favour the
hypothesis of a direct participation of YhjDR134C in trans-
membrane movement of lipid IVA. The hypothesis is based
on the assumption that theArg to Cys substitution results in
a modified YhjD protein, which can now transit lipid IVA
molecules across the IM. This in turn relieves a lethal
bottleneck in lipid IVA transport, supplementing the insuffi-
cient amounts of lipid IVA being translocated by MsbAalone
and restoring viability.
The hypothesis of a direct participation of YhjDR134C in
lipid IVA transmembrane transport in KPM22 is strongly
supported by the msbA knockout experiments that showed
MsbA is non-essential in the presence of the yhjD400
suppressor mutation. The strain KPM272 (KPM22 DmsbA)
is shown to possess an OM composed predominantly of
tetraacylated lipid A species (Fig. 5B), which suggests an
alternative translocation pathway for lipid IVA molecules in
KPM22 and related strains. We propose YhjDR134C plays a
key role in supplying the amounts of underacylated lipid
A precursors required for OM biogenesis. Like lipid IVA
previously identified in the IM of KPM22 (Meredith et al.,
2006), the lipid A precursors remaining localized in the IM
of KPM272 (Fig. 5A) appear to have no detrimental effects
on the bacterial cells. Recently, a direct role of MsbA in
phospholipid transport across the IM of E. coli has been
suggested (Zhou et al., 1998; Doerrler et al., 2001; 2004),
whereas MsbA apparently did not play any role in translo-
cation of phospholipids in Neisseria meningitidis (Tefsen
et al., 2005). Other studies have reported the ATP-
independent transbilayer movement of lipids by hydro-
phobic membrane-spanning a-helical proteins as an
alternative to the concept of lipid flip-flop by the activity of
dedicated proteins such as ABC transporters (Kol et al.,
2003; 2004). The synthesis of an OM by the msbA null
mutant KPM272 argues against a direct role of MsbA in
phospholipid transport also in E. coli, although we cannot
entirely exclude the possibility that the MsbA-independent
supply of phospholipids for OM biogenesis is specifically
associated with the genetic background of KPM272, i.e.
a compensatory function of YhjDR134C in transmembrane
trafficking of phospholipids as well.
We consistently observed varying but elevated levels of
P-EtN-modified lipid IVA in suppressor strains defective in
Kdo transfer like KPM121 and KPM231 (Fig. 2A and C). In
particular, the DmsbA knockout strain KPM272 expresses
lipid IVA molecules substituted with two P-EtN groups
(Fig. 5). Lipid A covalently modified with P-EtN is normally
not a constituent of the LPS of E. coli K-12 when grown
in LB medium, and only polymyxin-resistant mutants of
E. coli K-12 (Nummila et al., 1995) and wild-type cells
exposed either to mild acidic conditions (Gibbons et al.,
2005) or ammonium metavanadate (Zhou et al., 1999)
have so far been shown to modify lipid A with P-EtN. We
did not address the question of which phosphate position
of the lipid IVA in KPM121, KPM231 or KPM272 is P-EtN-
substituted. The transfer of P-EtN occurs predominantly
to the 1-phosphate group of lipid A at the periplasmic face
of the IM (Doerrler et al., 2004), whereas temperature-
640 U. Mamat et al. 
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Molecular Microbiology, 67, 633–648
sensitive KdsA mutants of S. enterica sv. Typhimurium
were shown to accumulate lipid A precursors upon shift
to non-permissive temperatures that are substituted
independently of Kdo with a P-EtN group solely at
the 4′-phosphate position (Strain et al., 1985; Zhou et al.,
2000; 2001). In KPM121, KPM231 and KPM272,
however, lipid IVA presumably is transported with
increased rates to the OM. Therefore, we must also con-
sider the possibility that lipid IVA, accessible at the peri-
plasmic side of the IM while translocated to the OM, is
modified with P-EtN at the 1-phosphate group in E. coli
K-12 suppressor strains lacking Kdo.
The capability to suppress the lethal DKdo phenotype
is not restricted to YhjDR134C. Here we also show that Pro
to Ser substitutions either at position 18 or at residue
number 50 of MsbA enable E. coli K-12 strains to survive
non-conditionally with null mutations in Kdo pathway
genes, including gutQ/kdsD and waaA. Although the YhjD
and MsbA suppressor proteins confer viability, there are
likely subtle differences in the OM composition due to
varying rates of lipid IVA transport in the different suppres-
sor strains. Strains defective in LPS biosynthesis translo-
cate phospholipids to the outer leaflet of the OM. As
demonstrated with EDTA-treated E. coli cells (Jia et al.,
2004) and E. coli mutants under conditions of Imp/RlpB
depletion (Wu et al., 2006), the palmitate transferase
PagP on the outer surface of the OM is capable of using
these outer leaflet phospholipids as palmitoyl donors to
modify LPS molecules (Bishop et al., 2000). We did not
detect lipid IVB in KPM22 (Meredith et al., 2006), KPM121,
KPM22 L1 and KPM272 but have identified a palmitoy-
lated fraction of lipid IVA molecules in KPM231, suggest-
ing the presence of phospholipids patches in the outer
leaflet OM that are being used by PagP to modify lipid IVA.
Our data give reason to suggest that the msbA52 and
msbA148 suppressor mutations in KPM22-like mutants
relax the high substrate specificity of MsbA for mature
LPS. The msbA52 mutation in KPM22 L11 was not further
characterized, but MsbAP18S basically confers the same
phenotype as found in all investigated YhjDR134C and
MsbAP50S suppressor strains, i.e. the cells are viable
despite perhaps predominantly synthesizing lipid IVA and
no Kdo. The current data do not allow us to determine
if the msbA mutations increase substrate promiscuity
during active, ATP-dependent transport or facilitate
passive transport of LPS precursors. In either case, the
substitution of proline residues as a prerequisite for
increasing the substrate promiscuity of MsbA supports the
key role of proline residues in determining the structure
and function of a-helical membrane proteins (Cordes
et al., 2002). To gain insight to possible structural and
functional consequences of the msbA52 and msbA148
suppressor mutations, we generated a threading model of
the primary amino acid sequence of wild-type MsbA from
E. coli onto the crystal structure for the homodimeric
S. aureus ABC transporter Sav1866 in the ADP-bound
outward-facing conformation (Dawson and Locher, 2006)
(Fig. 6). A similarly generated model for LmrA was
recently published (Federici et al., 2007). As MsbA of
E. coli and Sav1866 share significant overall sequence
similarity of 63% (Fig. S1), the fundamental assumption in
the creation of our model is that the structure of MsbA is
nearly identical to that of Sav1866. The threading model is
not intended as a starting point for quantitative computa-
tional studies, but rather to provide a qualitative tool for
Fig. 6. Threading model of the homodimeric MsbA from E. coli
in coil representation, with the monomers coloured blue and grey.
The primary amino acid sequence of MsbA was threaded onto the
crystal structure for the ABC transporter Sav1866 of S. aureus in
the ADP-bound outward-facing conformation (Dawson and Locher,
2006) as described in Experimental procedures. The N-terminal
helix and transmembrane helix (TMH) 1 are highlighted in red,
TMH2 and TMH3 in green. The Pro residues of both monomers are
shown as spheres. Pro18 and Pro50, substituted to Ser in the
suppressor proteins MsbAP18S and MsbAP50S, respectively, are
coloured magenta. All other labelled Pro residues depict the sites
suggested for substitution (see Discussion). The PyMOL software
[DeLano, 2002; The PyMOL Molecular Graphics System
(http://www.pymol.org)] was used to present the threading model.
TMDs, transmembrane domains; NBDs, nucleotide binding
domains; N-ter, N-terminus; ECL, extracellular loop; ICL,
intracellular loop.
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generation of hypotheses, illustration and discussion. A
more rigorous foundation for future studies must await the
release of the corrected MsbA crystal structures (Chang
et al., 2006).
The homodimeric Sav1866 has been recently sug-
gested as a reliable structural model for the core archi-
tecture of all ABC exporters (Dawson et al., 2007;
Hollenstein et al., 2007). Sav1866 comprises two ‘half-
transporters’ with two identical subunits, each containing
a hydrophilic cytoplasmic nucleotide-binding domain
(NBD) for ATP binding and hydrolysis, and a hydrophobic
transmembrane domain (TMD), determining the specific-
ity for the substrate and forming the pathway through
which the substrate is transported. Furthermore, the struc-
ture of Sav1866 in complex with ADP (Dawson and
Locher, 2006) and AMP-PNP (Dawson and Locher, 2007)
is thought to be in good agreement with the previously
proposed ‘ATP-switch’ model for the transport cycle of
ABC transporters (Higgins and Linton, 2004), which
describes the binding of ATP to the NBD and ‘closed
dimer’ formation as the driving force for the conforma-
tional changes involved in substrate transport, by conver-
sion of a high-affinity binding site of the substrate on the
TMDs at the cytoplasmic side of the membrane into
a low-affinity site exposed at the extracellular face of
the membrane. Conversely, ATP hydrolysis and ADP-Pi
release are expected to reset the transporter to its basal
inward-facing ‘open dimer’ configuration.
The predicted intercalation of Sav1866 in the IM
(Dawson and Locher, 2006) suggests the N-terminal helix
near Pro18 of the MsbA model on the interface between
the cytoplasm and the IM, and Pro50 at the junction
between transmembrane helix (TMH) 1 and extracellular
loop (ECL) 1 on the periplasmic side of the IM. In an
ATP-independent model for passage of lipid IVA, the Pro
to Ser substitutions may simply confer enough flexibility to
MsbA to facilitate passive translocation of lipid IVA across
the IM. The Pro50 residue is located at a position in
the model structure where a substitution to Ser could
decrease rigidity and relax substrate discrimination. A
decrease in the rigidity of TMH1 or perhaps a change in
the bend of ECL1 may contribute to substrate promiscuity.
As there could be an electrostatic contribution by the
hydroxyl group of Ser, substitutions of Pro50 to Gly, Ala or
Val should provide additional understanding as to whether
hydrogen bonding plays a role. We suppose that muta-
tions in any of the TMD prolines could provide new
insights into MsbA function and selection of lipid A species
for trafficking. Substitution of Pro68, which is not located
in the extrusion cavity, could decrease the rigidity of ECL1
in the same area as Pro50, whereas Pro297 and Pro273
would be interesting to substitute because of their analo-
gous arrangement relative to Pro50 and Pro68, inside the
cavity but lower down and outside the chamber but higher
up respectively. The intracellular loops (ICLs) represent
the shared interface between the NBDs and the TMDs
(Dawson and Locher, 2006). Pro112 at the junction of
TMH2 and ICL1, and basically located at the base of the
extrusion cavity between TMH2 and TMH3 would be
another interesting candidate for substitution.
The location of the Pro to Ser substitution at residue
number 18 favours currently two, though not altogether
unrelated possibilities of structural perturbation. First,
the perpendicular orientation of the N-terminal a-helical
segment at the interface between the cell interior and the
IM seems to hold the bundles of transmembrane helices
in a fixed position. The P18S mutation could ‘loosen’ the
bundle to allow the entry of lipid IVA into the translocation
pathway. In addition, provided that the N-terminal helix is
positioned at the entry site into the channel between the
two MsbA monomers, lipid IVA could enter the channel via
a less rigid ‘gate’ in MsbAP18S. Mutating Pro22 could shed
further light on this.
As mentioned, it must be considered that lipid IVA
remains subject to an ATP-dependent transport cycle.
This requires the specific binding of the substrates to one
or more substrate binding sites located on the TMDs
(Higgins and Linton, 2004). While it is not surprising
that point mutations may alter the substrate specificity of
ABC transporters (Armandola et al., 1996; Ozvegy et al.,
2002), it is currently difficult to explain why the Pro to Ser
substitutions at different sites in MsbA confer one and the
same phenotypes on the KPM22-like suppressor strains.
As substrate binding and conformational changes are
assumed to be required for ATP binding (Higgins and
Linton, 2004), the most straightforward explanation for our
data is that the initiation of the ATP-dependent transport
cycle is actually accomplished by binding of lipid IVA to
two different sites in MsbAP18S and MsbAP50S, either to
modulated high-affinity binding site(s) for hexaacylated
lipid A and LPS molecules, or to cryptic binding site(s) for
the tetraacylated lipid A precursor. On the other hand, it
is attractive to speculate that the proposed structural
changes at the sites of Pro to Ser substitutions, discussed
in the context of passive lipid IVA translocation, are suffi-
cient to act as continuous inducing signals for ATP
binding. This poses the question of whether (i) an initial
high-affinity binding of lipid IVA to MsbAP18S and MsbAP50S
is required at all to trigger its ATP-dependent transport,
and (ii) the suggested modes for lipid IVA translocation
may overlap or even complement one another.
The previous construction of the Kdo-deficient strain
KPM22 (Meredith et al., 2006) has not only challenged
the Kdo2-lipid A LPS dogma of E. coli, but also affords the
unique opportunity to obtain new insights into lipid A traf-
ficking and OM biogenesis by identification and analysis
of mutations that suppress Kdo dependence (Meredith
et al., 2006; Raetz et al., 2007). In addition to the strains
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that carry the herein reported suppressor mutations in
the yhjD and msbA genes, we have also isolated a third
class of KPM22-like mutants that retain wild-type alleles
for both yhjD and msbA genes (U. Mamat and R.W.
Woodard, unpublished). This suggests the existence of a
number of suppressors capable of compensating for the
lethal DKdo phenotype, and should further illuminate the
complex process of LPS trafficking in E. coli.
Experimental procedures
Bacterial strains, plasmids and growth conditions
All strains and plasmids used in the present study are
described in Table 2. Bacteria were routinely grown aerobi-
cally with shaking (250 r.p.m.) at 37°C in standard Luria–
Bertani (LB) medium containing 10 g l-1 of NaCl to maintain a
non-mucoid phenotype in DKdo strains (Meredith et al.,
2007). For growth of TCM15, containing deletions in the API
genes gutQ and kdsD, 15 mM A5P was added along with
10 mM D-glucose 6-phosphate (G6P) to induce the Uhp sugar
phosphate transport system (Eidels et al., 1974; Meredith
and Woodard, 2005). Non-conditional derivatives of TCM15
were derived in MOPS-minimal medium with 0.2% glycerol
as has been described (Meredith et al., 2006). Growth rates
were determined using cultures in early exponential growth
phase by monitoring the OD600 of the cell suspensions. In
order to induce LPS biosynthesis (Meredith et al., 2006) and
therefore restore the receptor for phage P1 adsorption, KPM
strains used as donors in P1vir transductions were grown in
the presence of 15 mM A5P and 10 mM G6P prior to phage
infection.
Mapping of suppressor mutations
Genetic mapping of suppressor mutations was performed by
P1vir transduction according to standard protocols (Miller,
Table 2. Bacterial strains and plasmids used in this study.
Strains or plasmids Description Source or reference
Strains
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F′ proAB lacI qZDM15
Tn10 (TetR)]
Stratagene
DY378 E. coli K-12 W3110 lcI857 D(cro-bioA) Yu et al. (2000)
BW30270 E. coli K-12 MG1655 rph +fnr + CGSC#7925
TCM15 BW30270 DgutQ DkdsD; A5P auxotroph Meredith and Woodard (2005)
KPM22 Non-conditional TCM15 derivative; yhjD400 Meredith et al. (2006)
KPM22 L1 Non-conditional TCM15 derivative; msbA148 This study
KPM22 L11 Non-conditional TCM15 derivative; msbA52 This study
KPM96 TCM15 yhjD400 treF::Tn903 This study
KPM121 MAW01 DwaaA This study
KPM129 TCM15 msbA148 Tn903 + This study
KPM231 MAW02 DwaaA This study
KPM272 KPM22 DmsbA This study
MAW01 BW30270 yhjD400 treF::Tn903 This study
MAW02 BW30270 msbA148 Tn903 + This study
MAW03 TCM15 DyhjD This study
MAW04 MAW03 with pT7LOHyhjD This study
MAW05 MAW03 with pT7LOHyhjD400 This study
MAW06 KPM22 DyhjD This study
MAW07 MAW06 with pT7LOHyhjD This study
MAW08 MAW06 with pT7LOHyhjD400 This study
MAW09 DY378 DmsbA::kan with pK-Cla This study
Plasmids
pNK2859 AmpR, KmR; transposon delivery plasmid; carries miniTn10 derivative Tn903 Kleckner et al. (1991)
pKD46 AmpR; l Red recombinase expression plasmid Datsenko and Wanner (2000)
pKD3 AmpR, CmR; template plasmid for chloramphenicol resistance cassette Datsenko and Wanner (2000)
pKD4 AmpR, KmR; template plasmid for kanamycin resistance cassette Datsenko and Wanner (2000)
pCP20 AmpR, CmR; FLP recombinase expression plasmid Datsenko and Wanner (2000)
pUC18 AmpR; high-copy-number general cloning vector Invitrogen
pT7LOH AmpR; T7 expression vector for N-terminal HisTag fusions Muda et al. (2002)
pK-Cla AmpR; pREG153 carrying a 3.8 kb KpnI–ClaI insert with msbA and lpxK of
E. coli
Karow and Georgopoulos (1993)
pT7LOHyhjD pT7LOH carrying the yhjD gene of BW30270 This study
pT7LOHyhjD400 pT7LOH carrying the yhjD400 gene of KPM22 This study
pMMW84 pUC18 carrying a 7.1 kb EcoRI insert of KPM96 with gadA′, yhjA, treF::Tn903
and yhjB
This study
pMMW86 pUC18 carrying a 15.3 kb PstI insert of KPM96 with gadA′, yhjA, treF::Tn903,
yhjB, yhjC, yhjD400, yhjE, yhjG, yhjH, kdgK and yhjJ′
This study
pMMW91 pUC18 carrying a 7.2 kb PstI insert of KPM129 with ycaO′, ycaP, serC, aroA,
ycaL′ and Tn903
This study
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1992). Tn903 transposon libraries of strains KPM22 and
KPM22 L1 harbouring the transposon delivery plasmid
pNK2859 were constructed as described previously (Kleck-
ner et al., 1991), followed by generation of transducing P1vir
lysates from pools of the donors carrying randomly inserted
chromosomal Tn903 insertions. Transduction of TCM15
recipient cells with P1vir lysates, followed by dual marker
selection for kanamycin resistance (30 mg ml-1 kanamycin)
and loss of A5P auxotrophy on LB agar, yielded the
co-transductants KPM96 and KPM129, respectively. The
kanamycin resistance marker along with the suppressor
mutations were then moved from KPM96 and KPM129 into
the parent E. coli K-12 wild-type strain BW30270 genetic
background by P1vir transduction to obtain strains MAW01
and MAW02, respectively. Co-transduction frequencies were
estimated in all experiments by transduction of TCM15 using
P1vir lysates from potential co-transductants and selected for
resistance to kanamycin on LB agar containing 30 mg ml-1
kanamycin, 15 mM A5P and 10 mM G6P, followed by scoring
of the kanamycin-resistant transductants for loss of A5P aux-
otrophy on LB agar only.
DNA manipulations
Standard recombinant DNA methods were used for nucleic
acid preparation and analysis (Sambrook and Russell, 2001).
Primer sequences are listed in Table 3. To localize the inte-
gration sites of the Tn903-derived kanamycin resistance cas-
sette, EcoRI- or PstI-digested genomic DNA fragments from
KPM96 and KPM129 were ligated into the EcoRI or PstI site
of pUC18. XL1-Blue transformants were selected on LB agar
containing 30 mg ml-1 kanamycin and 100 mg ml-1 ampicillin.
The entire DNA insert contained in two KPM-96 derived
clones [pMMW84 (7.1 kb) and pMMW86 (15.3 kb)] was
directly sequenced, whereas the sequence of the chromo-
somal region of KPM129 downstream of the pMMW91 insert
was determined on overlapping PCR products obtained with
the primer pairs ECOycaOP1/ECOycaLP1 and ECOycaLP2/
ECOlpxKP1. In mapping subsequent suppressor mutants,
clones were initially screened for known mutant alleles by
BsiWI and MwoI restriction analysis, respectively, prior to
sequencing. Primer pairs ECOyhjDP1/ECOyhjDP2 and
ECOmsbAP1/ECOmsbAP2 were used to amplify the yhjD
and msbA genes for sequencing.
Chromosomal yhjD and waaA deletions were constructed
using the phage l Red recombinase procedure as described
(Datsenko and Wanner, 2000), except chloramphenicol was
used at 10 mg ml-1 for selection. Primer pairs ECOyhjDH1/
ECOyhjDH2 with pKD4 (kanamycin) or ECOwaaAH1/
ECOwaaAH2 with pKD3 (chloramphenicol) as templates
were used to construct the insert cassettes targeting yhjD
of TCM15 and KPM22, and waaA of MAW01 and MAW02,
respectively. Antibiotic resistance markers were excised by
the FLP recombinase system essentially as described (Dat-
senko and Wanner, 2000), except plasmids pKD46 and
pCP20 were cured at 37°C to accommodate the temperature-
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et al., 2006). The resulting strains were designated MAW03
(TCM15 DyhjD), MAW06 (KPM22 DyhjD), KPM121 (MAW01
DwaaA) and KPM231 (MAW02 DwaaA). Both the yhjD gene
and the yhjD400 allele were amplified using the primers
ECO5NdeIyhjD and ECO3BamHIyhjD, followed by cloning
of the NdeI- and BamHI-treated PCR products into the ex-
pression vector pT7LOH to construct the complementation
vectors pT7LOHyhjD and pT7LOHyhjD400, respectively.
To delete the msbA gene in KPM22, the kanamycin resis-
tance cassette targeting msbA was amplified from pKD4
(Datsenko and Wanner, 2000) with primers ECOmsbAH1 and
ECOmsbAH2. The resulting PCR product was inserted into
the chromosome of l Red strain DY378 (Yu et al., 2000)
containing a wild-type msbA allele on plasmid pK-Cla to
sustain viability (Karow and Georgopoulos, 1993). The Dms-
bA::kan insert was transferred subsequently from MAW09 to
KPM22 by P1vir transduction, followed by excision of the
kanamycin resistance marker in the presence of pCP20 (Dat-
senko and Wanner, 2000) and removal of the helper plasmid
to yield strain KPM272. Strain genotypes are listed in Table 2.
Competitive RT-PCR
The msbA competitor RNA was synthesized in vitro by tran-
scription with T7 RNA polymerase in accordance with the
instructions of the supplier (Fermentas). The template for in
vitro transcription was generated by PCR using genomic
DNA of BW30270 as a template and the primer pair
5T7msbAcRTPCR/3msbAcRTPCR to fuse a T7 promoter to
the PCR product and introduce a 23 bp deletion into the
msbA target sequence spanning the region between nucle-
otides 646 and 668. Total RNA stabilized with RNAprotect
reagent (Qiagen) was isolated from late-exponential-phase
cultures using the RNeasy mini kit system as recommended
by the manufacturer (Qiagen). RNA samples were further
purified by treatment with 4 U RNase-free DNase (Amplifica-
tion Grade, Invitrogen), phenol/chloroform/isoamyl alcohol
extraction and ethanol precipitation. The integrity of the RNA
samples was inspected by agarose gel electrophoresis under
denaturing conditions in glyoxal as described (Burnett, 1997).
For quantification of the msbA target mRNA, serial dilutions
of msbA competitor RNA were spiked with equal amounts of
total RNA (1 mg) and subjected to cDNA synthesis in reaction
mixtures containing primer 3msbAcRTPCR, 40 U RiboLock
RNase inhibitor and 200 U RevertAid H Minus M-MuLV
reverse transcriptase according to the manufacturer’s proto-
col (Fermentas). Subsequent DNA amplifications of the target
and competitor sequences were performed using the primers
5msbALC1 and 3msbALC1. Aliquots of the PCR products
were separated on 2% agarose gels and visualized by stain-
ing with ethidium bromide. Quantitative densitometry of the
digitized agarose gels was performed with the Quantity One
software (Bio-Rad). The amount of the target was calculated
by determining the competition equivalence point of target
and competitor amplification products as described (Zimmer-
mann and Mannhalter, 1996).
Generation of an MsbA threading model
The primary amino acid sequence of wild-type MsbA from
E. coli was threaded onto the crystal structure for the
S. aureus ABC transporter Sav1866 (Dawson and Locher,
2006), using the homology modelling tools of the MOE soft-
ware package [The Molecular Operating Environment
(MOE), version 2007.05, Chemical Computing Group, Mont-
real, Quebec, Canada]. The amino acid sequences of MsbA
and Sav1866 were aligned using default settings in MOE with
the only constraint that the Arg4 of Sav1866 aligned with the
Arg15 of MsbA to generate the alignment shown in Fig. S1.
The 3.0 Å resolution crystal structure for Sav1866 was
obtained from the Protein Data Bank (PDB ID: 2HYD).
Models were generated for each monomer separately while
maintaining the relative co-ordinate frame of the 2HYD
structure. The default settings of MOE were used with the
exceptions that the number of intermediate models was
increased from 10 to 50 and the best intermediate was mini-
mized to ‘fine’, a more stringent criterion than the default
setting. On completion, the two monomers were joined
together to form the complete MsbA dimer. The AMBER99
force field, as implemented in MOE (Ponder and Case,
2003), was used in a series of energy minimizations to relax
the threaded structure. First hydrogen atoms, then hydrogen
and side-chain atoms were allowed to relax while keeping all
other atoms fixed. Backbone atoms were then also allowed to
relax using a series of minimizations in which they were
tethered with decreasing force to their starting positions.
Finally, all atoms were allowed to relax with no constraints to
a final gradient of 0.0001 kcal mol-1 Å-1 producing the model
displayed in Fig. 6.
Lipid IVA isolation
The biomass of stationary-phase cultures grown in 2 l of LB
medium (KPM22 L1) or LB medium containing 30 mg ml-1
kanamycin (KPM121 and KPM231) at 37°C with vigorous
shaking (250 r.p.m.) was extracted using a modified phenol-
chloroform-light petroleum (PCP) protocol (Galanos et al.,
1969) in which lipid IVA is recovered from the organic phase
by extensive dialysis against distilled water before lyophiliza-
tion (Meredith et al., 2006).
Separation of the IM and OM
Isolation of the membrane fraction from a late-exponential-
phase culture of KPM272 grown in 2 l of LB medium at 37°C
with vigorous shaking (250 r.p.m.), as well as separation of
the IM and OM by discontinuous sucrose gradient centrifu-
gation, was performed as described recently (Meredith et al.,
2006). Sucrose within the pooled IM and OM fractions was
removed by extensive dialysis against distilled water before
lyophilization and lipid IVA isolation by the modified PCP
procedure (Meredith et al., 2006).
ESI FT-ICR mass spectrometry
ESI FT-ICR mass spectrometry was performed in the nega-
tive ion mode using an APEX II and a hybrid Apex Qe Instru-
ment (Bruker Daltonics) equipped with a 7 Tesla actively
shielded magnet. Details on sample preparation and mass
spectrometry characteristics of LPS have been published
(Kondakova and Lindner, 2005).
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Note added in proof
After the acceptance of our manuscript, corrected MsbA
structures were published [Ward, A. et al. (2007) Proc Natl
Acad Sci USA 104: 19005–19010]. Our predicted MsbA
model is in excellent agreement with the crystal structure for
MsbA of S. enterica sv. Typhimurium; RMSD of 2.7 Å, well
under the structure resolution of 3.7 Å. We therefore believe
that the crystal structure in no way alters the interpretation of
our experimental data using the computationally derived
MsbA model.
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